Westin Diplomat
Hollywood Beach, Florida
June 16 – 19, 2014

“New Approaches to Mental Illness in the Era of the National Brain Initiative”

The American Society of Clinical Psychopharmacology (ASCP) is excited to announce the name change for the annual meeting.  What has been known as NCDEU for the past 60 years will now be the Annual Meeting for the American Society of Clinical Pharmacology.   The 2014 ASCP Annual Meeting is co-sponsored by the WPA.

The annual meeting will remain a scientific meeting that focuses on the latest developments in psychopharmacologic clinical research and related methodology. The meeting brings together over 1200 academic and industry investigators, research pharmacists, nurses, social workers, psychologists, and other clinicians, including competitively selected New Investigator awardees. In addition to the topics noted below, the meeting program includes presentations and information from the American Society of Clinical Psychopharmacology (ASCP) and its federal partners, the National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Institute on Alcohol Abuse and Alcoholism, (NIAAA), the Food and Drug Administration (FDA), and the European Medicines Agency (EMA).

  • ASCP focuses on timely issues in psychiatric clinical research including:
  • Implementation of clinical trials design, methodology, diagnosis, clinical assessment, patient ascertainment, and recruitment.
  • Measurement of functional outcomes for psychosocial and biomedical intervention research across a range of disorders and diverse populations.
  • Utilization of new technologies that can advance the development of new interventions.
  • Translation of new findings/research into knowledge or action to improve practices.

The program emphasizes the presentation of information that has not been previously published or presented.

Target Audience: Pharmacists, Psychologists, Social Workers, Clinicians, Academic and Industry Investigators